Novo, Lilly Slide After Biden Calls for Cheaper Obesity Drugs
(Bloomberg) — Shares of Novo Nordisk A/S and Eli Lilly & Co. fell on Tuesday as US President Joe Biden continued his push for cheaper drugs by demanding price cuts for their blockbuster weight loss and diabetes drugs. Most Read by Bloomberg Companies are paying “unconscionably high prices” that are above those paid in other … Read more